| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |